0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Vaccines for Pandemic Influenza (Paperback, 2009 ed.) Loot Price: R8,634
Discovery Miles 86 340
Vaccines for Pandemic Influenza (Paperback, 2009 ed.): Richard W. Compans, Walter A. Orenstein

Vaccines for Pandemic Influenza (Paperback, 2009 ed.)

Richard W. Compans, Walter A. Orenstein

Series: Current Topics in Microbiology and Immunology, 333

 (sign in to rate)
Loot Price R8,634 Discovery Miles 86 340 | Repayment Terms: R809 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans, resulting in numerous fatalities. The rapid expansion in their geographic distribution and the possibility that these viruses could acquire the ability to spread from person to person raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have little or no antigenic relationship to the highly pathogenic H5N1 strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop eff- tive vaccines for pandemic influenza viruses, and to overcome the limitations inh- ent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine prod- tion, which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations include the requirement that the current inac- vated influenza vaccines be administered using needles and syringes, requiring trained personnel, which could be a bottleneck when attempting to vaccinate large populations in mass campaigns. In addition, the current inactivated vaccines that are delivered by injection elicit limited protective immunity in the upper respiratory tract where the infection process is initiated.

General

Imprint: Springer-Verlag
Country of origin: Germany
Series: Current Topics in Microbiology and Immunology, 333
Release date: November 2011
First published: 2009
Editors: Richard W. Compans • Walter A. Orenstein
Dimensions: 235 x 155 x 27mm (L x W x T)
Format: Paperback
Pages: 512
Edition: 2009 ed.
ISBN-13: 978-3-642-24240-3
Categories: Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 3-642-24240-5
Barcode: 9783642242403

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners